Abstract The development of drugs targeting Nutrient Stimulated Hormone receptors has ushered in a dramatic change in our approach to weight management because of their ability to achieve weight losses of 10%, 20%, even 30% in significant numbers of patients
Use our free tool to find out if you have a case and qualify for financial compensation
Peptides 23:14911495 Fras JP, Guja C, Hardy E, Ahmed A, Dong F, hman P, Jabbour SA (2016) Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
doi:10.3389/fgene.2016.00095 Swope VB, Abdel-Malek ZA
It also protects implants